STRICTLY CONFIDENTIAL Predictive Oncology Inc.Engagement Agreement • March 16th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledMarch 16th, 2020 Company Industry Jurisdiction
STRICTLY CONFIDENTIALEngagement Agreement • July 5th, 2018 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 5th, 2018 Company Industry JurisdictionThis amended and restated letter agreement (this “Agreement”), which amends and restates in its entirety that certain engagement letter, dated as of June 28, 2018, entered into by the parties hereto, constitutes the agreement between Oramed Pharmaceuticals Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”) that Wainwright shall serve as the U.S. exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (“Securities”) during the Term (as defined below) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation an